Panel features developers discussing applications of wearable, AI, VR, and other assistive technologies in psychedelics for enhanced cost-effectivity and patient outcomes in medicine.
David M Rabin, Nanea Reeves, Nichol Bradford
Psilocybin service center facilitator discusses ceremonies and natural medicines in Colorado and Oregon's new state frameworks for participation in natural medicine practices.
William Wildcat Coakee, Sean McAllister, Dave Kopilak
MDMA optimizes brain chemistry for safety, openness, and compassion. AEDP uses relational interventions to enhance MDMA's effects in trauma therapy, fostering trust, intimacy, and healing attachment.
Kari Gleiser
Speaker discusses underlying assumptions of psychedelic therapy and therapist's role, emphasizing presence in facilitating healing. Draws from personal experiences with MDMA, psilocybin, and ketamine research volunteers.
Norma Stevens
Therapists and religious professionals discuss ethical considerations in using psychedelics with vulnerable individuals, emphasizing the need for integrity and accountability in the psychedelic profession.
Cedar Barstow, Jennifer C Jones
Sandell and colleagues discuss the benefits and risks of experiential training in psychedelic therapy for therapists, including potential therapeutic and theoretical functions, as well as risks like dual relationships and
Emma Hapke, Daniel Rosenbaum
Lauren Taus, a psychedelic assisted therapist, discusses a new approach to drugs, family, and healing in therapy sessions and educational programs at Inbodied Life.
Internal Family Systems (IFS) therapy, developed over four decades, offers evidence-based techniques to guide clients towards Self, fostering inner clarity and compassion. IFS provides a safe and healing map for
Richard Schwartz
Dr. Bennett explores the expanding field of ketamine treatment, covering current trends, controversies, and potential topics like enantiomers, mail order platforms, provider training, economics, and FDA approval challenges.
Roots To Thrive Non Profit pioneers legal psilocybin group therapy in North America, with published research, ongoing trials, and ties to a Canadian academic program. Emphasizing community in psychedelic mental
Todd Haspect, Akua Prieto Brown
© 1986 – 2025 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mailing: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.